Cleveland Clinic Parkinson's Study Group

(All times listed are in Eastern Time)

8:30 AM Sign on and Exhibits
8:55 AM Introduction and Welcome Remarks
Hubert Fernandez
Moderator: Marie Saint-Hilaire
9:00 AM Convention vs Innovation I: Telemedicine/Virtual Visits Should Now Be A Preferred Option For Following 
         Patients With PD After Diagnosis
Agree : Zoltan Mari

Disagree : Susan Fox
10:00 AM Convention vs Innovation II: Time To Abandon Clinician-Administered Scales As The Primary Outcome
          Measure Of Symptomatic And Disease Modifying Trials in Parkinson's Disease

Agree : Tiago Mestre

Disagree : Tanya Simuni
11:00 AM Break/Exhibits
Liana Rosenthal
11:30 AM Nature vs. Nurture ENCORE topic: Genetically-Targeted Trials And Not Immunotherapy-Based Trials Will
          Lead Us To Our First Successful Disease Modifying Therapy

Agree : Anne-Marie Willis

Disagree : Andrew Siderowf
12:30 PM Hope vs. Hype I: Istradefylline's "non-dopaminergic" Mechanism of Action Provides a Unique And Significant
           Advantages in PD Treatment

Agree : Peter LeWitt

Disagree : Michael Schwarzschild
1:30 PMBreak/Exhibits
2:00 PM Hope vs. Hype II: Closed Loop Technology Will Provide More Meaningful Improvement vs. Directional Leads
          In Deep Brain Stimulation

Agree : Helen Bronte-Stewart

Disagree : Aristide Merola
3:00 PMHow to Design A Clinical Trial in COVID-19 Times
Hubert Fernandez
(All times listed are in Eastern Time)
8:30 AM

Sign on and Exhibits 

8:55 AM Welcome Remarks
Michael Schwarzchild

Allison Willis

9:00 AM Enough vs More: Neuropsychological Testing is More Useful Than Genetic Testing In The Baseline PD Evaluation

Agree : Michele York

Disagree : Roy Alcalay
10:00 AM Update on Genetics in Parkinson's Disease
Martha Nance
10:45 AMBreak/Exhibits
Moderator: Hubert Fernandez
11:00 AM Progress in Behavioral And Non-Motor Therapies in PD
Gregory Pontone
11:45 AM New "On-Demand" Therapies For PD: Racing a Thoroughbred Horse, or Beating a Dead One? 
Fernando Pagan
12:30 PM Break/Exhibits
CME Program Adjourns
1:00 PM - 1:45 PM Optional Non-CME Session:
The Most Promising Symptomatic Trials in PD
William Ondo